在固体瘤中,仿真抗原受体-T细胞疗法的挑战和干预措施
Shasha Liu1,2, Yi Zhang1,2,3,4
1Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
概括
化学抗原受体 (CAR) -T细胞疗法对固体瘤有希望,但面临挑战. 新的奥米克和生物材料策略正在出现,以克服这些障碍,以改善免疫治疗.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 采用细胞疗法,特别是CAR-T细胞疗法,已经改变了血液恶性瘤治疗.
- 显著的挑战阻碍了在固体瘤中更广泛的应用,包括耐药性和免疫抑制微环境.
研究的目的:
- 审查对固体瘤CAR-T细胞疗法的最近临床进展.
- 突出克服治疗障碍的挑战和新兴战略.
主要方法:
- 对当前的临床进展进行前性审查.
- 讨论挑战和创新策略,包括omics和生物材料.
主要成果:
- 卡特-T细胞疗法显示出潜力,但在固体瘤中面临障碍.
- 多维欧米和生物材料为提高效率提供了有希望的途径.
结论:
- 克服抗性,瘤微环境和T细胞耗尽对于固体瘤的CAR-T细胞治疗至关重要.
- 新技术对于在固体瘤治疗中推进细胞免疫疗法至关重要.
相关概念视频
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K